Zeus Industrials Round-Up - 9 May 2024

Economic and industrial data has started the second quarter on slightly weaker grounds than Q1 as Manufacturing PMI in the UK, Eurozone and US all reported April indexes below March levels. Cracks seem to be appearing as recent drops in new orders and rising input costs are quickly dampening confidence. Inflation did, however, fall MoM across the board with the exception of the US, where volatile energy prices caused a modest MoM increase in the inflation rate.

Hybridan Small Cap Feast - 28 Feb 24

28th February 2024 @HybridanLLP Status of this Note and Disclaimer This document has been issued to you by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to such action. This document has no regard for the specific investment obj

AB Dynamics (ABDP LN) - Resilient trading; now better value

As with many watchers of ABD, we admire the market leading automotive testing technology, market positions and balance sheet capacity, but rarely like the valuation.

AB Dynamics (ABDP LN) - Up with events

Earnings are resilient, acquisitions look sensible, and ABD has a healthy net cash position. But the shares have outperformed, and ABD’s valuation is looking full.

Hybridan Small Cap Feast - 11 Jan 23

11 January 2023 @HybridanLLP Status of this Note and Disclaimer This document has been issued to you by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to such action. This document has no regard for the specific investment object

AB Dynamics (ABDP) - Highway star

There is not much wrong with the investment case for ABD currently. Earnings are resilient, acquisitions look sensible, and the Group has a net cash position. Many investors will simply not like the valuation (PE c.30x forward), but ABD has always been expensive, priced as a rare provider of value-added testing equipment and services for vehicle active safety and autonomy. Some will worry about supply chain constraints, but we have not heard anything different or particularly concerning from ABD

Hybridan Small Cap Feast 23/11/2022

Dish of the day Joiners: No joiners today. Leavers: No leavers today. What’s cooking in the IPO kitchen?** Kistos Holdings plc, intends to join AIM. The Company was incorporated to act as a new holding company for the group companies 0f Kistos plc (KIST), a holding company with the objective of creating value for its investors through the acquisition and management of companies or businesses in the energy sector. Anticipated Market Cap £327m. Expected 22 Dec 2022. AT85 Global Mid-Market Infrastr

AB Dynamics (ABDP LN) - Back to growth, delivery required

ABD needs to offer investors higher earnings growth and returns to justify its premium rating, in our view. Just reported H1 results were solid (Revenue up 39% to £37.8m, adjusted operating profit up 63% to £5.7m) and indicate a healthy recovery in trading. Full year earnings are guided to be slightly higher, and we lift our operating profit estimate by 3.6% to £11.7m. That said, this outturn would still be significantly below the peak of £13.5m reported in 2019a. ABD has a plan to restore highe

Hybridan Small Cap Feast 23/03/22

Joiners: RC365 Holding has joined the Main Market (Standard). Founded in Hong Kong in 2013, the Group is a fintech solutions service provider in China and Hong Kong, and is looking to expand its payment gateway services into Europe and the UK. In connection with Admission, the Company successfully raised approx. £2m for the Group at a price of 6.2p per ordinary share. At the Issue Price, the Company's market capitalisation will be approx. £6.7m. Leavers: No Leavers Today. What’s cooking in the I

Hybridan Small Cap Feast 12/02/22

Genflow Biosciences, a UK-based biotechnology company focused on longevity and the development of therapies to counteract the effects of aging and diseases associated with advanced age intends to float on the Main Market (Standard). The Company will become the first longevity biotechnology firm to list in Europe. Genflow has raised £3.7m in an oversubscribed placing, conditional upon admission becoming effective. The flotation will value Genflow at approximately £23.4m. SuperSeed Capital Limited

Hybridan Small Cap Feast 28/09/2021

Joiners Petershill Partners (PHLL.L), has joined the Main Market (Premium), a leading investment group providing bespoke capital and strategic solutions to some of the world's best performing alternative asset management firms. Petershill Partners today comprises minority investments in 19 high-quality Partner-firms, previously held in private funds managed by Goldman Sachs Asset Management (GSAM). The Partner-firms have US$187 bn of aggregated assets under management. The Offer would comprise (

Small Cap Feast

Umuthi Healthcare (UHS.L) , the technology led healthcare business focused on the distribution of pharmaceuticals and the provision of medical facilities in remote areas has joined the main market (standard). No funds raised. Umuthi onboarded 2,000 clients during the previous financial year which represents a single digit fraction of the immediately available customers to its MedTech platform and have booked revenues as a result of these sales, ensuring tangible proof of concept. The bespoke p

LIBERUM: Luceco: Trading comfortably in line

OPG Power Ventures - Positive update for FY March 2024

OPG Power has released a positive trading update for the year ended 31 March 2024, and now expects to exceed previous market expectations at the EBITDA and revenue level. The company continued to benefit from a stronger revenue run-rate during H2/24 compared with FY23, reflecting greater availability of profitable supply contracts, which in turn have enabled OPG to run at higher levels of plant utilisation. We are raising our revenue forecast for FY24 by 22% to £162m, and our EBITDA by 34% to £1

Morning Note – 13 May 2024

Norcros (NXR LN) - Capital Markets Day – taking the next step

Norcros recently hosted a Capital Markets Day (CMD) signalling a change in how the business communicates with the market. In recent history it has focused on growing its share of the highly fragmented bathroom and kitchen product markets organically and through acquisition. This has resulted in a portfolio of businesses with varying degrees of capital intensity and profitability but created a Group of scale (c. £450m revenue) with strong positions in its end markets. Last week’s CMD was evidence

LIBERUM: Currys: Improving momentum drives material beat and third consecutive upgrade

SP Angel Spec Sits HERC.LN: Positive trading update

Hercules is likely to report growth in H1E of over 27% YoY. H1E is the seasonally weaker half and the reported likely outcome for revenues in H1E represents half of our FY24E revenue forecast. As the seasonally stronger half of the year progresses, upwards pressure could materialise on our forecasts. Together with a prospective lower interest rate environment and a potential re-rating of the infrastructure sector, we see share price upside ahead.

SP Angel Morning View: Gold pushes higher as rate cut optimism resurfaces as labour market cools

Ultimate Products - Q3 trading update: tougher short-term, better longer-term

Ultimate Products’ Q3 trading update reveals that tougher short-term trading trends are now likely to persist into Q4, but the longer-term trends are now more positive due to growing order visibility from its bigger customers. We are downgrading our EPS (Dil. Adj.) forecasts by 22% to 12.5p from 16.0p for FY24E, by 15.3% to 14.8p from 17.4p in FY25E and by 12.6% to 16.6p from 19.0p for FY26E. We reduce our target price to 185p (was 210p) to reflect the new forecasts. Shorter-term issues should r

Hardman & Co Insight: 2023 was an annus horribilis for Quoted UK Infrastructure and Renewable Energy

The focus of Hardman & Co Research is on the nine quoted Infrastructure Investment Companies (IICs) and on the 22 Renewable Energy Infrastructure Funds (REIFs): the stocks analysed are all members of the Association of Investment Companies (AIC). We are updating our publication of January 2023, assessing both the lacklustre share price performances during 2023 and the key issues, including interest rates, inflation and power prices. As a 31-strong group, its combined market capitalisation is no

OPG Power Ventures - Interim results – solid progress, FY24 forecasts maintained

OPG Power has published interim results for the period ended 30 September. The company reports a strong balance sheet position and a sharp increase in plant utilisation driven by new supply contracts as discussed at the time of the FY23 results release in November. We believe that OPG continues to make a strong recovery following the coal price spike which impacted FY23. We are raising our target price to 27p, which represents 108% upside to the latest closing price.

Hercules Site Services - Trading in-line with expectations

Hercules has released a positive H1 trading update, with revenue up 27% YoY to c.£47m and growth delivered across all three of the group’s divisions (Labour Supply, Civil Projects, Specialist Plant Services). Trading remains in-line with expectations for the full year as demand for infrastructure remains robust. We leave our forecasts unchanged, but note that Hercules has already achieved 49% of our FY24E revenue projections (vs an average of 42%/58% H1/H2 split over the past three years), which

Near term disruption, but growth case remains strong

Ultimate Products announces today that sales revenue fell by 7% in its FY2024 third quarter and is anticipated to remain in negative territory in Q4. As a result, the company believes that EBITDA will now be in the range of £17.5m to £18.5m compared with a current market consensus figure of £21.5m. Given the 17% cut in current year EBITDA expectations it seems prudent to adjust our fair value / share figure by a similar amount. So, we reduce it by 20% from 250p to 200p. However, current sales s

Further good growth in H1, in line with expectations

Hercules’ H1 trading update confirms another period of strong growth, in line with expectations. Revenue in H1’24 is expected to be over £47m, an increase of c.27% over H1’23. This represents c.50% of our FY’24 forecast (£94.7m), suggesting the Group is well on track at the half year stage. All income streams grew, underpinned by substantial demand from the infrastructure sector, as well as the Group’s own growth initiatives. Contract momentum remains positive, and we note an encouraging trend

LIBERUM: Ilika: Proposed placing to drive Goliath roadmap

Eden Research - Fruitful year

Eden Research has reported its interim results for the 12 months to December 2023. The company generated revenues of £3.2m, slightly ahead of the January trading updated expectation of £3.1m and c15% ahead of our forecast. We note the company generated strong gross profits and an adjusted EBITA ahead of our forecast, both of which we believe were supported by the first commercial sale of Ecovelex. The company closed FY23 with cash slightly below our forecast, which we believe was impacted by the